Title: Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-
associated fatty liver disease: usefulness of non-invasive steatosis predictive scores.
Version: 4 Date: 27 Sep 2023
Reviewer's report:
As I had mentioned earlier in my previous review report that this is a very promising work which
has a non-invasive approach of detecting the group of IBD patients having a co-morbidity of
MAFLD.
After the revision by the authors, I think it is now appropriate to be published without any farther
delay.
Title: Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-
associated fatty liver disease: usefulness of non-invasive steatosis predictive scores.
Version: 4 Date: 27 Sep 2023
Reviewer's report:
As I had mentioned earlier in my previous review report that this is a very promising work which
has a non-invasive approach of detecting the group of IBD patients having a co-morbidity of
MAFLD.
After the revision by the authors, I think it is now appropriate to be published without any farther
delay.
Please review this paper.
user
Title: Identifying inflammatory bowel disease patients at risk of metabolic dysfunction-
associated fatty liver disease: usefulness of non-invasive steatosis predictive scores.
Version: 4 Date: 27 Sep 2023
Reviewer's report:
As I had mentioned earlier in my previous review report that this is a very promising work which
has a non-invasive approach of detecting the group of IBD patients having a co-morbidity of
MAFLD.
After the revision by the authors, I think it is now appropriate to be published without any farther
delay.
assistant